Skip to main content
. 2017 Oct 9;75(6):989–1000. doi: 10.1007/s00018-017-2676-9

Fig. 2.

Fig. 2

Strategy for iPSC-derived NPC transplantation in SCI patients. CiRA at Kyoto University has already provided clinical grade human iPSCs. We have established differentiation protocol into NPCs and its derivatives. Now we conduct detailed analysis for these cells to secure the efficacy and safety